Intranasal Administration of a Naked Plasmid Reached Brain Cells and Expressed Green Fluorescent Protein, a Candidate for Future Gene Therapy Studies.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archives of Medical Research

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.arcmed.2018.03.003PMID 29555303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

  2017cited by this paper
• Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer’s Disease

  2016cited by this paper
• Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain

  2014cited by this paper
• Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model.

  2014cited by this paper
• Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.

  2013cited by this paper
• A Rapid Gene Delivery–Based Mouse Model for Early-Stage Alzheimer Disease–Type Tauopathy

  2013cited by this paper
• Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.

  2013cited by this paper
• Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.

  2013cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.

  2012cited by this paper
• Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration.

  2012cited by this paper
• Intranasal anti-rabies DNA immunization promotes a Th1-related cytokine stimulation associated with plasmid survival time.

  2011cited by this paper
• Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.

  2011cited by this paper
• Cell-penetrating DNA-binding protein as a safe and efficient naked DNA delivery carrier in vitro and in vivo.

  2010cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

  2008cited by this paper
• Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins

  2008cited by this paper
• Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally.

  2008cited by this paper
• Rabies DNA vaccination by the intranasal route in dogs.

  2006cited by this paper
• Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  2006cited by this paper
• Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications

  2005cited by this paper
• Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.

  2004cited by this paper
• Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

  2003cited by this paper
• Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery.

  2001cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway

  1998cited by this paper
• THE OLFACTORY BULBS IN EXPERIMENTAL POLIOMYELITIS: THEIR PATHOLOGIC CONDITION AS AN INDICATOR OF THE PORTAL OF ENTRY OF THE VIRUS

  1937cited by this paper
• The nasal mucosa and the subarachnoid space

  1937cited by this paper

• Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs

  2022cites this paper
• Intranasal delivery of biotechnology-based therapeutics.

  2022cites this paper
• Increase of 5-HT levels is induced both in mouse brain and HEK-293 cells following their exposure to a non-viral tryptophan hydroxylase construct

  2021cites this paper
• Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain

  2020cites this paper
• Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures

  2020cites this paper
• Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

  2018cites this paper